1. Hollander E (1993) In: Hollander E (ed) Obsessive–Compulsive Related Disorders, American Psychiatric Publishing, Inc, Washington, DC, pp 1–16.
2. Hollander E, Stein DJ, DeCaria CM, et al. (1992) Disorders related to OCD—neurobiology. Clin Neuropharmacol 15(S1)Pt A:259A–260A. [PubMed] 3. McElroy SL, Phillips KA, Keck PE Jr (1994) Obsessive compulsive spectrum disorder. J Clin Psychiatry 55(Suppl):33–51;discussion 52–3. [PubMed]
4. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn. text revision. American Psychiatric Association, Washington, DC .
5. Asahi S, Okamoto Y, Okada G, et al. (2004) Negative Correlation between right prefrontal activity during response inhibition and impulsiveness: a fMRI study. Eur Arch Psychiatry Clin Neurosci 254(4):245–251. [PubMed] 6. Rufer M, Fricke S, Held D, et al. (2006) Dissociation and symptom dimensions of obsessive compulsive disorder: a replication study. Eur Arch Psychiatry Clin Neurosci 256(3):146–150. [PubMed]
7. Gerstein D, Volberg RA, Harwood H, et al. (1999) Gambling impact and behavior study. Report to the National Gambling Impact Study Commission. National Opinion Research Center at the University of Chicago, Chicago.
8. Welte J, Barnes G, Wieczorek Q, et al. (2001) Alcohol and gambling pathology among U.S. adults: prevalence, demographic patterns and comorbidity. J Studies Alcohol 62:706–712 .
9. Shaffer H, Hall M, Vander Bilt J (1997) Estimating the prevalence of disordered gambling behavior in the United States and Canada. A meta-analysis. Presidents and Fellows of Harvard College, Boston .
10. Abbott MW, Volberg RA (2000) Taking the pulse on gambling and problem gambling in New Zealand. A report on Phase One of the 1999. National Prevalence Survey. Department of International Affairs, Wellington.
11. Abbott MW (2001) Problem and non problem Gamblers in New Zealand: a report on Phase II of the 1999 National Prevalence Survey. Report Number 6 of the New Zealand Gambling Survey. Department of International Affairs, Wellington .
12. Abbott MW (2001) What do we know about gambling and problem gambling in New Zealand: a report on Phase II of the 1999 National Prevalence Survey. Report Number 7 of the New Zealand Gambling Survey. Department of International Affairs, Wellington .
13. Ronnberg S, Volberg RA, Abbott MW, et al. (1999) Gambling and problem gambling in Sweden. Report Number 2 of the National Institute of Public Health Series on Gambling. National Institute of Public Health, Stockholm.
14. Volberg RA, Abbott MW, Ronnberg S, et al. (2001) Prevalence and risks of pathological gambling in Sweden. Acta Psych Scand 104:250–256 .
15. Bondolfi G, Osiek C, Ferrero F (2000) Prevalence estimates of pathological gambling in Switzerland. Acta Psych Scand 101:473–475 .
16. Productivity Commission: Australia’s gambling industries. Report No. 10. Canberra. AusInfo.
17. Sproston K, Erens R, Oxford J (2000) Gambling behavior in Britain. Results from the British gambling prevalence survey. National Centre for Social Research, London .
18. Roy A, Adinoff B, Roehrich L, et al. (1988) Depressed pathological gamblers. Acta Psychiatr Scand 77:163–165. [PubMed]
19. National Research Council (1999) Pathological gambling: a critical review. National Academy Press, Washington, DC .
20. Linden RD, Pope HG, Jonas JM (1986) Pathological gambling and major affective disorders: preliminary findings. J Clin Psychiatry 47:201–203. [PubMed] 21. Potenza MN, Fiellin DA, Hieninger GR, et al. (2002) Gambling: an addictive behavior with health and primary care implications. J Gen Intern Med 17(9):721–732. [PMC free article] [PubMed] 22. Hollander E, Pallanti S, Allen A, et al. (2005) Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? Am J Psychiatry 162(1):137–145. [PubMed]
23. Dell’Osso B, Allen A, Hollander E (2005) Comorbidity issues in the pharmacological treatment of pathological gambling: a critical review. Clin Pract Epidemol Ment Health Oct 10;1(1):21.
24. Hantouche E, Merckaert P (1991) Nosological classifications of obsessive–compulsive disorder. Ann Med Psychol 149:393–408 .
25. Hollander E, Skodol A, Oldham J (1996) Impulsivity and compulsivity. American Psychiatric Press, Washington, DC .
26. Cartwright C, DeCaria C, Hollander E (1998) Pathological gambling: a clinical review. Practical Psychiatry and Behavioral Health 4:277–286 .
27. Lesieur HR (1979) The compulsive gambler’s spiral of options and involvement. Psychiatry 42:79–87. [PubMed]
28. Leisieur HR, Custer RL (1984) Pathological gambling: roots, phases and treatment. Ann Acad Poll Soc Sci 474:146–156 .
29. Rasmussen SA, Eisen JL (1992) The epidemiology and differential diagnosis of obsessive–compulsive disorder. J Clin Psychiatry 53:4–10. [PubMed]
30. Argo TR, Black DW (2004) Clinical characteristics. In: Grant JE, Potenza MN (eds) Pathological Gambling: A Clinical Guide to Treatment. American Psychiatric Publishing, Inc, Washington, DC, pp 39–53 .
31. Swedo E, Rapoport JL (1991) Annotation: trichotillomania. J Child Psychol Psychiatry 32:401–409. [PubMed] 32. Christenson GA, Pyle RL, Mitchell JE (1991) Estimated lifetime prevalence of trichotillomania in college students. J Clin Psychiatry 52:415–417. [PubMed]
33. Stanley MA, Borden JW, Bell GE, et al. (1994) Nonclinical hair-pulling phenomenology and related psychopathology. J Anxiety Disord 8:119–130 .
34. Swedo SE, Trichotillomania (1993) In: Hollander E (ed) Obsessive–compulsive related disorders, American Psychiatric Publishing, Inc, Washington, DC, pp 93–113 and 256.
35. Lenane MC, Swedo SE, Rapoport JL, et al. (1992) Rates of Obsessive Compulsive Disorder in first degree relatives of patients with trichotillomania: a research note. J Child Psychol Psychiatry 33(5):925–33. [PubMed] 36. Stein DJ, Simeon D, Cohen LJ, et al. (1995) Trichotillomania and obsessive–compulsive disorder. J Clin Psychiatry 56(S4):28–34. [PubMed]
37. Christenson GA, Mansueto CS (1999) descriptive characteristics and phenomenology. In: Stein DJ, Christenson GA, Hollander E (eds) Trichotillomania. American Psychiatric Publishing, Inc, Washington, DC, pp 1–42 .
38. Simeon D, Favazza AR (1995) Self-injurious behaviors, phenomenology and assessment. In: Simeon D, Hollander E (eds) Self-injurious behaviors, assessment and treatment. American Psychiatric Publishing, Inc, Washington, DC, pp 1–28 .
39. Lochner C, Seedat S, du Toit PL, et al. (2005) Obsessive–compulsive disorder and trichotillomania: a phenomenological comparison. BMC Psychiatry 5:2. [PMC free article] [PubMed] 40. Jacobson RR (1985) Child firesetters. a clinical investigation. J Child Psychol Psychiatry 26:759. [PubMed] 41. Kosky RJ, Silburn S (1984) Children who light fires: a comparison between firesetters and non-firesetters referred to a child psychiatrist outpatient service. Aust N Z J Psychiatry 18:251–255. [PubMed] 42. Kolko DJ, Kadzin AE (1988) Prevalence of firesetting and related behaviors among child psychiatric patients. J Consult Clin Psychol 56:628–630. [PubMed] 43. Barnett W, Spitzer R (1994) Pathological firesetting 1951–1991: a review. Med Sci Law 34:4–20. [PubMed] 44. Strachan JG (1981) Conspicuous firesetting in children. Br J Psychiatry 138:26–29. [PubMed]
45. Jones RT, Langley AK, Penn C (2001) Firesetting. In: Orvaschel H, Faust J (eds) Handbook of conceptualization and treatment of child psychopathology. Pergamon/Elsevier, Amsterdam, pp 355–378 .
46. Raines JC, Foy CW (1994) Extinguishing the fires within: treating juvenile firesetters. Fam Soc-J Contemp H 75:595–606 .
47. Soltys SM (1992) Pyromania and firesetting behaviors. Psychiatr Ann 22:79–83 .
48. Jesor R, Jesor SL (1977) Problem behavior and psychosocial development. Academic Press, New York .
49. Stickle TR, Blechman EA (2002) Aggression and fire: antisocial behavior in firesetting and nonfiresetting juvenile offenders. J Psychopathol Behav Assess 24:177–193 .
50. Geller JL (1987) Firesetting in the adult psychiatric populations. Hosp Commun Psychiatry 38:501–506 .
51. Chen YH, Arria AM, Anthony JC (2003) Firesetting in adolescence, and being aggressive, shy, and rejected by peers: New epidemiologic evidence from a national sample survey. J Am Acad Psychiatry Law 31:44–52. [PubMed] 52. Monopolis S, Lion JR (1983) Problems in the diagnosis of intermittent explosive disorder. Am J Psychiatry 140:1200–1202. [PubMed] 53. Felthous AR, Bryant G, Wingerter CBV, et al. (1991) The diagnosis of intermittent explosive disorder in violent men. Bull Am Acad Psychiatry Law 19:71–79. [PubMed] 54. Coccaro EF, Schmidt CA, Samuels JF, et al. (2004) Lifetime and 1-Month Prevalence Rates of Intermittent Explosive Disorder in a Community Sample. J Clin Psychiatry 65:820–824. [PubMed]
55. American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders, 3rd edn, text revision. Washington, DC, American Psychiatric Association .
56. Coccaro EF, Kavoussi RJ, Berman RE, et al. (1998) Intermittent explosive disorder-revised: development, reliability and validity of research criteria. Compr Psychiatry 39:368–376. [PubMed]
57. Coccaro EF (2003) Intermittent explosive disorder. In: Coccaro EF (eds) Aggression, psychiatric treatment and assessment. Marcel Dekker, New York, NY, pp 149–166 .
58. McElroy SL, Soutullo CA, Beckman DA, et al. (1998) DSM-IV intermittent explosive disorder: a report of 27 cases. J Clin Psychiatry 59:203–210. [PubMed] 59. du Toit PL, van Kradenburg J, Niehaus D, et al. (2005) Comparison of obsessive–compulsive disorder in patients with and without comorbid putative obsessive compulsive spectrum disorders using a structured clinical interview. Compr Psychiatry 42:291–300. [PubMed] 60. Fontenelle LF, Mendlowicz MV, Versiani M, et al. (2005) Impulse control disorders in patients with obsessive–compulsive disorder. Psychiatry Clin Neurosci 59:30–37. [PubMed] 61. Matsunaga H, Kiriike N, Matsui T, et al. (2005) Impulsive disorders in Japanese adult patients with obsessive–compulsive disorder. Compr Psychiatry 46:105–110. [PubMed] 62. Aboujaoude E, Gamel N, Koran LM (2004) Overview of Kleptomania and Phenomenological Description of 40 Patients. Prim Care Companion J Clin Psychiatry 6:244–247. [PubMed] 63. Goldman MJ (1991) Kleptomania: making sense of the nonsensical. Am J Psychiatry 148:986–996. [PubMed] 64. McElroy SL, Pope HG, Hudson JL, et al. (1991) Kleptomania: a report of 20 cases. Am J Psychiatry 148:652–657. [PubMed]
65. Hollinger RC, Davis JL (2003) 2002 National retail security survey final report. University of Florida, Gainesville Fla .
66. Goldman MJ (1998) Kleptomania. The compulsion to steal- what can be done? New Horizon Press, Far Hills, NJ .
67. Grant JE, Kim SW (2002) Clinical characteristics and associated psychopathology of 22 patients with kleptomania. Compr Psychiatry 43:378–384. [PubMed] 68. Presta S, Marazziti D, Dell’Osso L, et al. (2002) Kleptomania: clinical features and comorbidity in an Italian sample. Compr Psychiatry 43:7–12. [PubMed] 69. Grant JE (2003) Family History and Psychiatric Comorbidity in Persons with Kleptomania. Compr Psychiatry 44:437–441. [PubMed] 70. Stein DJ (1997) Internet addiction, internet psychotherapy [letter; comment]. Am J Psychiatry 153:890. [PubMed] 71. Shapira NA, Goldsmith TD, Keck PA, et al. (2000) Psychiatric features of individuals with problematic Internet use. J Affect Disord 57:(issues 1–3):267–272. [PubMed] 72. Beard KW (2005) Internet addiction: a review of current assessment techniques and potential assessment questions. Cyberpsychol Behav 8:7–14. [PubMed]
73. Cho C, Hsiao MC (2000) Internet Addiction, usage, gratification, and pleasure experience: the Taiwan college students’ case. Comput Educ 35:65–80 .
74. Young KS (1998) Caught in the net. John Wiley & Sons, New York .
75. Scherer K (1997) College-life online: healthy and unhealthy Internet use. J Coll Student Dev 38:655–665 .
76. Young KS (1996) Psychology of computer use: XL. Addictive use of the internet: a case that breaks the stereotype. Psychol Rep 79:899–902. [PubMed] 77. Black DW, Belsare G, Schlosser S (1999) Clinical Features, psychiatric comorbidity, and health-related quality of life in persons reporting compulsive computer use behavior. J Clin Psychiatry 60:839–844. [PubMed]
78. Shapira NA, Lessig MC, Goldsmith TD, et al. (2003) Problematic internet use: proposed classification and diagnostic criteria. Dep Anxiety 17:207–216 .
79. Black DW, Kehrberg LLD, Flumerfelt DL, et al. (1997) Characteristics of 36 subjects reporting compulsive sexual behavior. Am J Psychiatry 154:243–249. [PubMed]
80. Coleman E (1991) Compulsive sexual behavior. New concepts and treatments. J Psychol Hum Sexual 4:37–52 .
81. Schaffer SD, Zimmerman ML (1990) The sexual addict: a challenge for the primary care provider. Nurse Pract 15:25–33. [PubMed] 82. Cooper AJ, Swaminath S, Baxter D, et al. (1990) A female sex offender with multiple paraphilias: a psychologic, physiologic (laboratory sexual arousal) and endocrine case study. Can J Psychiatry 35:334–337. [PubMed]
83. Weissberg JH, Levay AN (1986) Compulsive sexual behavior. Medical Aspects Human Sexuality 20:129–132 .
84. Kafka MP, Prentky R (1994) Preliminary observations of DSM-III-R Axis I comorbidity in men with paraphilias and paraphilia-related disorders. J Clin Psychiatry 55:481–487. [PubMed] 85. McElroy SL, Keck Jr PE, Phillips KA. (1995) Kleptomania, compulsive buying and binge-eating disorder. J Clin Psychiatry 56(S4):14–26. [PubMed]
86. McElroy SL, Keck PE Jr, Pope HG Jr, et al. (1995) Compulsive buying: a report of 20 cases. J Clin Psychiatry 55–56:242–248 .
87. Black DW (2001) Compulsive buying disorder: definition, assessment, epidemiology and clinical management. CNS Drugs 15(1):17–27. [PubMed] 88. Christenson GA, Faber RJ, de Zwaan M, et al. (1994) Compulsive buying: descriptive characteristics and psychiatric comorbidity. J Clin Psychiatry 55:5–11. [PubMed] 89. Lejoyeux M, Bailly F, Moula H, et al. (2005) Study of compulsive buying in patients presenting obsessive–compulsive disorder. Compr Psychiatry 46:105–110. [PubMed]
90. Doran AR, Roy A, Wolkowitz OM (1985) Self destructive dermatoses. Psychiat Clin N Am 8:291–298 .
91. Gupta MA, Gupta AK, Haberman HR (1986) Neurotic excoriations: a review and some new perspectives. Compr Psychiatry 27:381–386. [PubMed] 92. Simeon D, Stein DJ, Gross S, et al. (1997) A double-blind trial of fluoxetine in pathologic skin picking. J Clin Psychiatry 58:341–347. [PubMed] 93. Arnold LM, McElroy SL, Mutasim DF, et al. (1998) Characteristics of 34 adults with psychogenic excoriation. J Clin Psychiatry 59:509–514. [PubMed] 94. Wilhelm S, Keuthen NJ, Deckersbach T, et al. (1999) Self-injurious skin picking: clinical characteristics and comorbidity. J Clin Psychiatry 60:454–459. [PubMed] 95. Blanco C, Petkova E, Ibanez A, et al. (2002) A Pilot Placebo-Controlled Study of Fluvoxamine for Pathological Gambling. Ann Clin Psychiatry 14:9–15. [PubMed] 96. Hollander E, DeCaria CM, Finkekk JN, et al. (2000) A randomized double-blind fluvoxamine/placebo crossover trial in pathological gambling. Biol Psychiatry 47(9):813–817. [PubMed] 97. Kim SW, Grant JE, Adson DE, et al. (2002) A Double-Blind Placebo-Controlled Study of the Efficacy and Safety of Paroxetine in the treatment of Pathological Gambling. J Clin Psychiatry 63:501–507. [PubMed] 98. Grant JE, Kim SW, Potenza MN, et al. (2003) Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial. Int Clin Psychopharmacol 18:243–249. [PubMed] 99. Kim SW, Grant JE, Adson DE, et al. (2001) Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 49(11):914–921. [PubMed] 100. Hollander E, DeCaria CM, Mari E, et al. (1998) Short-term single-blind fluvoxamine treatment of pathological gambling. Am J Psychiatry 155(12):1781–1783. [PubMed] 101. Zimmerman M, Breen RB, Posternak MA (2002) An open-label study of citalopram in the treatment of pathological gambling. J Clin Psychiatry 63(1):44–48. [PubMed] 102. Pallanti S, Baldini-Rossi N, Sood E, et al. (2002) Nefazodone treatment of pathological gambling: a prospective open-label controlled trial. J Clin Psychiatry 63(11):1034–1039. [PubMed] 103. Black DW (2004) An open-label trial of bupropion in the treatment of pathologic gambling. J Clin Psychopharmacol 24(1):108–110. [PubMed]
104. Grant John (2005) A multicenter Investigation of the Opioid Antagonist Nalmefene in the Treatment of Pathological Gambling. Presented at the 45th NCDEU Meeting, Boca Raton, Florida, June 6–9.
105. Swedo SE, Leonard HL, Rapoport JL, et al. (1989) A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling). N Engl J Med 321:497–501. [PubMed] 106. Stanley MA, Bowers TC, Swann AC, et al. (1991) Treatment of trichotillomania with fluoxetine. J Clin Psychiatry 52:282. [PubMed] 107. Koran LM, Ringold A, Hewlett W (1992) Fluoxetine for trichotillomania: an open clinical trial. Psychopharmacol Bull 28:145–149. [PubMed] 108. Winchel RM, Jones JS, Stanley B, et al. (1992) Clinical characteristics of trichotillomania and its response to fluoxetine. J Clin Psychiatry 53:304–308. [PubMed]
109. Stein DJ, Bouwer C, Maud CM (1997) Use of the selective serotonin reuptake inhibitor citalopram in the treatment of trichotillomania. Eur Arch Psy Clin N 247:234–236 .
110. Christenson GA, Crow SG, Mitchell JE, et al. (1998) Fluvoxamine in the treatment of trichotillomania: an 8-week, open-label study. CNS Spectrums 3:64–71 .
111. Christenson GA, Mackenzie TB, Mitchell JE, et al. (1991) A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania. Am J Psychiatry 148:1566–1571. [PubMed] 112. Streichenwein SM, Thornby JI (1995) A long-term, double-blind, placebo-controlled, crossover trial of the efficacy of fluoxetine for trichotillomania. Am J Psychiatry 152:1192–1196. [PubMed]
113. O’Sullivan RL, Keuthen NJ, Rodriguez D, et al. (1998) Venlafaxine treatment of trichotillomania: an open case series of ten cases. CNS Spectrums 3:56–63 .
114. Ninan PT, Knight B, Kirk L, et al. (1998) A controlled trial of venlafaxine in trichotillomania: interim phase I results. Psychopharmacol Bull 34(2):221–224. [PubMed] 115. Christenson GA, Mackenzie TB, Mitchell JE, et al. (1991) Lithium treatment of chronic hair pulling. J Clin Psychiatry 52:116–120. [PubMed]
116. Christenson GA, Crow JC, Mackenzie TB, et al. (1995) A placebo-controlled double-blind study of naltrexone for trichotillomania. Presented at the Annual Meeting of the American Psychiatric Association, Miami, Florida, May.
117. Stein DJ, Hollander E (1992) Low-dose pimozide augmentation of serotonin reuptake blockers in the treatment of trichotillomania. J Clin Psychiatry 53:123–126. [PubMed]
118. van Ameringen M, Mancini C (1996) Treatment of trichotillomania with haloperidol. Anxiety Disorders Association of America Annual Meeting. Orlando, FL.
119. Ninan PT, Rothbaum BO, Marsteller FA, et al. (2000) A placebo-controlled trial of cognitive-behavioral therapy and clomipramine in trichotillomania. J Clin Psychiatry 61(1):47–50. [PubMed] 120. Kolko DJ (2001) Efficacy of cognitive-behavioral treatment and fire safety education for children who set fires: initial and follow-up outcomes. J Child Psychol Psychiatry 42(3):359–369. [PubMed] 121. Slavkin ML (2002) Child & Adolescent Psychiatry: What Every Clinician Needs to Know About Juvenile Firesetters. Psychiatr Serv 53:1237–1238. [PubMed]
122. Coccaro EF (2000) Intermittent Explosive Disorder. CNS Drugs 2:67–71 .
123. Sheard MH, Marini JL, Bridges CI, et al. (1976) The effect of lithium on impulse aggressive behavior in man. Am J Psychiatry 133:1409–1413. [PubMed] 124. Campbell M, Small AM, Green WH, et al. (1984) Behavioral efficacy of haloperidol and lithium carbonate: a comparison in hospitalized aggressive children with conduct disorder. Arch Gen Psychiatry 41:650–656. [PubMed] 125. Campbell M, Adams PB, Small AM, et al. (1995) Lithium in hospitalized aggressive children with conduct disorder: a double blind and placebo controlled study. J Am Acad Child Adolesc Psychiatry 34:445–453. [PubMed] 126. Malone RP, Bennett DS, Luebbert JF, et al. (1998) Aggression classification and treatment response. Psychopharmacol Bull 34:41–45. [PubMed] 127. Malone RP, Delaney MA, Luebbert JF, et al. (2000) A double blind and placebo controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder. Arch Gen Psychiatry 57:649–654. [PubMed] 128. Lindenmayer JP, Kotsaftis A (2000) Use of sodium valproate in violent and aggressive behaviors: a critical review. J Clin Psychiatry 61:123–128. [PubMed] 129. Hollander E, Swann AC, Coccaro EF, et al. (2005) Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder. Am J Psychiatry 162(3):621–624. [PubMed] 130. Hollander E, Tracy KA, Swann AC, et al. (2003) Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders. Neuropsychopharmacology 28(6):1186–1197. [PubMed] 131. Foster HG, Hillbrand M, Chi CC (1989) Efficacy of carbamazepine in assaultive patients with frontal lobe dysfunction. Prog Neuropsychopharmacol Biol Psychiatry 13:865–874. [PubMed] 132. Mattes JA (1984) Carbamazepine for uncontrolled rage outbursts. Lancet II:1164–1165. [PubMed] 133. Barratt ES, Stanford MS, Felthous A, et al. (1997) The effects of phenytoin on impulsive and premeditated aggression: a controlled study. J Clin Psychopharmacol 17:341–349. [PubMed] 134. Stanford MS, Houston RJ, Mathias CW, et al. (2001) A double-blind placebo-controlled crossover study of phenytoin in individuals with impulsive aggression. Psychiatry Res 103:193–203. [PubMed] 135. Coccaro EF, Kavoussi RJ (1997) Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Arch Gen Psychiatry 54:1081–1088. [PubMed] 136. Greendyke RM, Kanter DR (1986a) Therapeutic effects of Pindolol on behavioral disturbances associated with organic brain disease: a double-blind study. J Clin Psychiatry 47:423–426. [PubMed] 137. Greendyke RM, Kanter DR, Schuster DB, et al. (1986b) Propranolol treatment of assaultive patients with organic brain disease. J Nerv Ment Dis 174:290–294. [PubMed]
138. Kemph JP, DeVane CL, Levin GM, et al. (1993) Treatment of aggressive children with clonidine: results of an open pilot study. J Am Acad Cild Adolesc Psychiatry 32:577–581 .
139. Buitelaar JK, Van der Gaag RJ, Cohen-Kettenis P, et al. (2001) A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities. J Clin Psychiatry 62:239–248. [PubMed]
140. Findling RL, McNamara NK, Branicky LA, et al. (2001) A double-blind pilot study of risperidone in the treatment of conduct disorder. J Am Acad Cild Adolesc Psychiatry 39:509–516 .
141. Alpert JE, Spilman MK (1997) Psychotherapeutic approaches to aggressive and violent patients. Psychiat Clin N Am 20:453–471 .
142. Edmondson CB, Conger JC (1996) A review of treatment efficacy for individuals with anger problems: conceptual, assessment and methodological issues. Clin Psychol Rev 16:251–275 .
143. Schwartz JH (1992) Psychoanalytic psychotherapy for a woman with diagnosis of kleptomania. Hosp Community Psychiatry 43:109–110. [PubMed] 144. Burstein A (1992) Fluoxetine-lithium treatment for kleptomania. J Clin Psychiatry 53:28–29. [PubMed] 145. SA, Low BL (1996) Treatment of kleptomania with fluvoxamine. Acta Psychiatr Scand 93(4):314–315. [PubMed] 146. Durst R, Katz G, Knobler HY (1997) Buspirone augmentation of fluvoxamine in the treatment of fluvoxamine in the treatment of kleptomania. J Nerv Ment Dis 185:586–588. [PubMed] 147. Lepkifker E, Dannon PN, Ziv R, et al. (1999) The treatment of kleptomania with serotonin reuptake inhibithors. Clin Neuropharmacol 22:40–43. [PubMed]
148. Dannon PN, Ianco I, Grunhaus L (1999) Naltrexone treatment in kleptomanic patients. Hum Psychopharm Clin 14:583–585 .
149. Kmetz GF, McElroy SL, Collins DJ (1997) Response of kleptomania and mixed mania to valproate. Am J Psychiatry 154:580–581. [PubMed] 150. Kim SW (1998) Opioid antagonists in the treatment of impulse-control disorders. J Clin Psychiatry 59:159–164. [PubMed] 151. Durst R, Katz G, Teitelbaum A, et al. (2001) Kleptomania: diagnosis and treatment options. CNS Drugs 15:185–195. [PubMed] 152. Sattar P, Ramaswamy S (2004) Internet gaming addiction. Can J Psychiatry 49(12):869–870. [PubMed]
153. Dell’Osso B, Altamura AC, Hadley SJ, Baker B, Hollander E (2006) An open label trial of escitalopram in the treatment of compulsive–impulsive Internet usage disorder. Eur Neuropsychopharmacol 16(S1):82–83 .
154. Griffiths MD, Woods RT (2000) Risk factors in adolescence: the case of gambling, videogame playing, and the internet. J Gambl Stud 16(2–3):199–225. [PubMed] 155. Stein DJ, Black DW, Shapira NA, et al. (2001) Hypersexual Disorder and Preoccupation With Internet Pornography. Am J Psychiatry 158:1590–1594. [PubMed]
156. Cesnik JA, Coleman E (1989) Use of lithium carbonate in the treatment of autoerotic asphyxia. Am J Psychoter 43:277–285 .
157. Coleman E, Cesnik J, Moore A, et al. (1992) An exploratory study of the role of psychotropic medications in treatment of sex offenders. J Offend Rehabil 18:75–88 .
158. Kruesi MJ, Fine S, Valladres L, et al. (1992) Paraphilias: A double-blind cross-over comparison of clomipramine versus desipramine. Arch Sex Behav 21:587–593. [PubMed] 159. Emmanuel NP, Lydiard RB, Ballenger JC (1991) Fluoxetine treatment of voyerism. Am J Psychiatry 148:950. [PubMed] 160. Kafka MP (1994) Sertraline pharmacotherapyfor paraphilias and paraphilia-related disorders: an open trial. Ann Clin Psychiatry 6:189–195. [PubMed] 161. Stein DJ, Hollander E, Anthony DT, et al. (1992) Serotonergic medications for sexual obsessions, sexual addiction, and paraphilias. J Clin Psychiatry 53:267–271. [PubMed]
162. Fedoroff JP (1993) Serotonergic drugs treatment of deviant sexual interests. Annals Sex Res 6:105–121 .
163. Fedoroff JP (1988) Buspirone hydrochloride in the treatment of transvestic feticism. J Clin Psychiatry 49:408–409. [PubMed] 164. Fedoroff JP (1992) Buspirone hydrochloride in the treatment of atypical paraphilia. Arch Sex Behav 21:401–406. [PubMed] 165. Coleman E, Gratzer T, Nesvacil L, et al. (2000) Nefazodone and the treatment of nonparaphilic compulsive sexual behavior: a retrospective study. J Clin Psychiatry 61:282–284. [PubMed] 166. Raymond NC, Grant JE, Kim SM, et al. (2002) Treatment of compulsive sexual behavior with naltrexone and serotonin reuptake inhibitors: two case studies. Int Clin Psychopharmacol 17:201–205. [PubMed]
167. Coleman E (1995) Treatment of compulsive sexual behavior. In: Rosen RC, Leiblum SR (eds) Case Studies in Sex Therapy. Guildford Press, New York, NY, pp 333–349 .
168. Black DW, Monahan P, Gabel J (1997) Fluvoxamine in the treatment of compulsive buying. J Clin Psychiatry 58:159–163. [PubMed] 169. Kim SW (1998) Opioid antagonists in the treatment of impulse-control disorders. J Clin Psychiatry 59(4):159–164. [PubMed]
170. Ninan PT, McElroy SL, Kane CP, et al. (2000) Placebo controlled study of fluvoxamine in the treatment of patients with compulsive buying. J Clin Psychopharmacol 20:363–366 .
171. Black DW, Gabel J, Hansen J, et al. (2000) A double-blind comparison of fluvoxamine versus placebo in the treatment of subjects with compulsive buying disorder. Ann Clin Psychiatry 12:205–211. [PubMed] 172. Koran LM, Bullock KD, Hartston HJ, et al. (2002) Citalopram treatment of compulsive shopping: an open-label study. J Clin Psychiatry 63(8):704–8. [PubMed] 173. Koran LM, Chuong HW, Bullock KD, et al. (2003) Citalopram for compulsive shopping disorder: an open-label study followed by double-blind discontinuation. J Clin Psychiatry 64(7):793–798. [PubMed] 174. Phillips KA, Taub SL (1995) Skin picking as a symptom of body dysmorphic disorder. Psychopharmacol Bull 31:289–288. [PubMed] 175. Block MR, Elliott M, Thompson H, et al. (2001) Fluoxetine in pathologic skin-picking: open-label and double-blind results. Psychosomatics 42(4):314–319. [PubMed] 176. Kalivas J, Kalivas L, Gilman D, et al. (1996) Sertraline in the treatment of neurotic excoriations and related disorders. Arch Dermatol 132:589–590. [PubMed]
177. Aronowitz B (2001) Psychotherapies for Compulsive Self-Injurious Behaviors. In: Hollander E, Simeon D (eds) Self-injurious behaviors: assessment and treatment. American Psychiatric Publishing, Inc., Washington, DC, pp 97–117 .